Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.70285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Sheng-Sheng Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Polysaccharides, Disease Progression. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Scientific Program of Translational Medicine Research Institute of Anhui Province of China, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Abnormal glycosylation is associated with tumors. The clinical value of serum glycans in assessing progression of hepatocellular carcinoma (HCC) patients remains a challenge.
Methods
A study dynamically comparing levels of fifteen lectin‐specific glycans between preoperative and postoperative serum of 65 HCC patients was conducted via lectin biochip technology. Multivariable logistic regression analysis was used to address associations between serum glycan levels and clinicopathological characteristics. Kaplan–Meier analysis was used to evaluate the impacts of serum glycan levels on overall survival (OS) and progression‐free survival (PFS) of the HCC patients.
Results
HCC patients presented significantly higher levels of the lectin‐specific glycans in preoperative serum than disease‐free individuals ( p < 0.001 − p = 0.029), except ConA. The glycans in preoperative sera were significantly related to tumor size, pTNM, metastasis, BCLC stage, portal hypertension (PHT), and platelet count (PLT), respectively ( p < 0.05). Multivariate logistic analyses indicated that tumor size and pTNM independently impact on glycan‐specific lectins either LTL, UEA‐I, VVL, NPL, WGA, PNA, MAL‐I, SNA, or PHA‐L ( p = 0.003 − p = 0.044); BCLC stage and PLT were independent factors influencing the serum glycans recognizable DSA ( p = 0.024) and SNA ( p = 0.050), respectively. Surgical excision of tumor mass significantly reduced glycan levels in sera. Tumor differentiation, albumin, and ABO type significantly revealed independent influence on glycan‐specific lectins, such as RCA‐I ( p = 0.024), VVL ( p = 0.024), and Con A ( p = 0.026) in the postoperative serum. HCC patients with high levels of VVL‐binding glycans significantly benefited from a longer OS time ( p = 0.016, HR: 0.460, 95% CI: 0.237–0.892) and a better PFS time ( p = 0.004; HR: 0.435, 95% CI: 0.237–0.799), respectively.
Conclusion
Serum glycans could reflect surgical outcomes in at‐risk patients and become valuable biomarkers in evaluating the progression of HCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital Anhui Medical University, Hefei, China.
- Department of Neurosurgery, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
- Department of Hepato-Biliary-Pancreas Surgery, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
- Department of Pathology, Anhui Medical University, Hefei, China.
ORCID-Profile: Wei-Dong Du
Förderung
- the Scientific Program of Translational Medicine Research Institute of Anhui Province of China
- the National Natural Science Foundation of China
Zitieren
APA
Liu, S. S., Ye, L., Dai, Q. Q., Gao, Y., Chen, G. H., Zhao, H. C., & Du, W. D. (2024). Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.70285
Vancouver
Liu SS, Ye L, Dai QQ, Gao Y, Chen GH, Zhao HC, et al. Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.70285
BibTeX
@article{Liu2024,
author = {Liu, Sheng-Sheng and Ye, Lei and Dai, Qing-Qing and Gao, Yi and Chen, Guang-Hou and Zhao, Hong-Chuan and Du, Wei-Dong},
title = {Preoperative Serum Glycan Levels Reflect Progression of Patients With Hepatocellular Carcinoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70285}
}
EUVIMED